IP Library › Assignment 044801/0254
Patent Assignment
Reel/Frame 044801/0254

License

Recorded: 2017-12-07 Pages: 73
Assignor
APEIRON BIOLOGICS AG
Executed: 2016-09-27
Assignee
EUSA PHARMA (UK) LIMITED
BREAKSPEAR PARK, BREAKSPEAR WAY, HEMEL HEMPTSTEAD, HP24TZ, UNITED KINGDOM
Covered Properties (2)
Method for Treating a GD2 Positive Cancer
Application: 15/700,538 →
Publication: US 2018/0134801
Preparations and Methods for Treating a GD2 Positive Cancer
Application: 15/824,055 →
Publication: US 2018/0258183
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 7, 2017
From: LOIBNER, HANS; SCHUSTER, MANFRED; JANZEK-HAWLAT, EVELYNE; WIEDERKUM, SUSANNE
To: APEIRON BIOLOGICS AG
Reel/Frame 044331/0555 →
Assignment of Assignor's Interest Dec 7, 2017
From: LOIBNER, HANS; MUTSCHLECHNER, OLIVER; LADENSTEIN, RUTH; KLIER, ISABEL
To: APEIRON BIOLOGICS AG
Reel/Frame 044331/0772 →
Change of Name Dec 10, 2024
From: APEIRON BIOLOGICS AG
To: APEIRON BIOLOGICS GMBH
Reel/Frame 069584/0365 →
Security Interest Dec 23, 2024
From: APEIRON BIOLOGICS GMBH
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 069669/0908 →